Research location
Ľubochňa
Slovakia
Advertisement
Research activity in Ľubochňa
SlovakiaCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 34 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ľubochňa
34 linked trials · page 1 of 1AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightNCT07533175 · 2026-04-13 · 1 site observation
RECRUITING
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightNCT07253285 · 2026-01-08 · 1 site observation
RECRUITING
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 1 site observation
RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03 · 1 site observation
COMPLETED
AMNIODERM+ Medical Device Clinical StudyNCT06442865 · 2022-11-16 · 1 site observation
COMPLETED
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation
COMPLETED
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesNCT03689374 · 2018-10-01 · 1 site observation
COMPLETED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesNCT03268005 · 2017-09-19 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodNCT02787551 · 2016-07-06 · 1 site observation
COMPLETED
Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistNCT02738151 · 2016-05-19 · 1 site observation
COMPLETED
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsNCT02666430 · 2015-12-01 · 1 site observation
COMPLETED
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot UlcersNCT02447172 · 2015-06-01 · 1 site observation
COMPLETED
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEINCT02370537 · 2015-03-01 · 1 site observation
COMPLETED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)NCT02227862 · 2014-06-01 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesNCT02058160 · 2014-01-01 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusNCT01952145 · 2013-09-20 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01468987 · 2011-12-01 · 1 site observation
COMPLETED
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesNCT01232491 · 2010-10-29 · 1 site observation
COMPLETED
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideNCT00968812 · 2009-09-01 · 1 site observation
COMPLETED
INTERPRET - International Report on Routine Practice of Sensor-enabled Pump TherapyNCT00790088 · 2009-02-01 · 1 site observation
COMPLETED
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 1 site observation
TERMINATED
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaNCT00523042 · 2007-08-30 · 1 site observation
TERMINATED
Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)NCT00472953 · 2007-05-15 · 1 site observation
TERMINATED
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.NCT00366249 · 2007-01-01 · 1 site observation
COMPLETED
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesNCT00300105 · 2005-10-01 · 1 site observation
TERMINATED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLANT 22 Tesaglitazar vs. PlaceboNCT00252837 · 2005-04-01 · 1 site observation
TERMINATED
GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesNCT00252876 · 2005-03-01 · 1 site observation
TERMINATED
GALLANT 4 Tesaglitazar vs. GlibenclamideNCT00255541 · 2004-09-01 · 1 site observation
TERMINATED
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.NCT00306696 · 2002-10-01 · 1 site observation
COMPLETED
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesNCT00379769 · 2001-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.